These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32693207)

  • 1. HLA-DR53 (DRB4∗01) associates with nickel sensitization.
    Zhang Y; Anderson KM; Freed BM; Dai S; Pacheco KA
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):614-616. PubMed ID: 32693207
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-DRB4*01:14 is a null allele, and renamed HLA-DRB4*01:14N.
    Fuerst D; Tsamadou C; Gowdavally S; Schrezenmeier H; Mytilineos J
    HLA; 2020 Jan; 95(1):73-75. PubMed ID: 31576671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB4 gene encoded HLA-DR53 specificity segregating with the HLA-DR7, -DQ9 haplotype: unusual association.
    Lardy NM; van der Horst AR; van de Weerd MJ; de Waal LP; Bontrop RE
    Hum Immunol; 1998 Feb; 59(2):115-8. PubMed ID: 9536434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HLA-DRB4 gene is present in half of the Spanish HLA-DQ2-negative celiac patients.
    Garrote JA; Arranz E; Blanco-Quirós A
    Immunogenetics; 2000 Oct; 51(12):1045-6. PubMed ID: 11061289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of the DRB4*0103102N null allele in different DRB1*04-positive individuals.
    Voorter CE; Lardy NM; van den Berg-Loonen EM
    Tissue Antigens; 2000 Jan; 55(1):37-43. PubMed ID: 10703606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB4 genotyping by PCR-RFLP: diversity in the associations between HLA-DRB4 and DRB1 alleles.
    Naruse TK; Ando R; Nose Y; Kagiya M; Ando H; Kawata H; Nabeya N; Isshiki G; Inoko H
    Tissue Antigens; 1997 Feb; 49(2):152-9. PubMed ID: 9062971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of association between HLA-DR4 and DR53 and autoantibody detection in rheumatoid arthritis.
    Zhou Y; Tan L; Que Q; Li H; Cai L; Cao L; Ye Q; Xiong J
    J Immunoassay Immunochem; 2013; 34(2):126-33. PubMed ID: 23537298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of Nickel Allergy.
    Saito M; Arakaki R; Yamada A; Tsunematsu T; Kudo Y; Ishimaru N
    Int J Mol Sci; 2016 Feb; 17(2):. PubMed ID: 26848658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia.
    Dorak MT; Lawson T; Machulla HK; Darke C; Mills KI; Burnett AK
    Blood; 1999 Jul; 94(2):694-700. PubMed ID: 10397736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis.
    Wan XL; Kimura A; Dong RP; Honda K; Tamai H; Sasazuki T
    Hum Immunol; 1995 Feb; 42(2):131-6. PubMed ID: 7744616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of anchor residues in a naturally processed HLA-DR53 ligand.
    Kobayashi H; Kokubo T; Abe Y; Sato K; Kimura S; Miyokawa N; Katagiri M
    Immunogenetics; 1996; 44(5):366-71. PubMed ID: 8781122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of HLA-DR1 and HLA-DR53 protects against MS.
    Luomala M; Elovaara I; Ukkonen M; Koivula T; Lehtimäki T
    Neurology; 2001 Feb; 56(3):383-5. PubMed ID: 11171905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL.
    Dorak MT; Oguz FS; Yalman N; Diler AS; Kalayoglu S; Anak S; Sargin D; Carin M
    Leuk Res; 2002 Jul; 26(7):651-6. PubMed ID: 12008082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules.
    Kinouchi R; Kobayasi H; Sato K; Kimura S; Katagiri M
    Immunogenetics; 1994; 40(5):376-8. PubMed ID: 7927542
    [No Abstract]   [Full Text] [Related]  

  • 15. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia.
    Dorak MT; Owen G; Galbraith I; Henderson N; Webb D; Mills KI; Darke C; Burnett AK
    Leukemia; 1995 May; 9(5):875-8. PubMed ID: 7769851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of the DRB4*01:03:01:02N null allele in HLA-DRB1~DQB1 haplotypes in the Croatian population.
    Grubic Z; Maskalan M; Radmanic L; Stingl Jankovic K; Burek Kamenaric M; Zunec R
    HLA; 2018 Jan; 91(1):23-28. PubMed ID: 29152917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene.
    Scaradavou A; Carrier C; Mollen N; Stevens C; Rubinstein P
    Blood; 1996 Aug; 88(4):1494-500. PubMed ID: 8695871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides.
    Futaki G; Kobayashi H; Sato K; Taneichi M; Katagiri M
    Immunogenetics; 1995; 42(4):299-301. PubMed ID: 7672826
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides.
    Clot F; Gianfrani C; Babron MC; Bouguerra F; Southwood S; Kagnoff MF; Troncone R; Percopo S; Eliaou JF; Clerget-Darpoux F; Sette A; Greco L
    Immunogenetics; 1999 Aug; 49(9):800-7. PubMed ID: 10398807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new DRB4 allele (DRB4*0104).
    De Canck I; Demanet C; Mersch G; Jannes G; Rombout A; Rossau R; Van Waeyenberge C
    Tissue Antigens; 1996 Sep; 48(3):213-6. PubMed ID: 8896182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.